Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

TLC

Taiwan Liposome (TLC)

Taiwan Liposome Company Ltd
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TLC
일자시간출처헤드라인심볼기업
2023/11/2017:54GlobeNewswire Inc.Highlights of Dr. David Hunter’s Oral Presentation at ACR’s Late Breaking Abstracts SessionNASDAQ:TLCTaiwan Liposome Company Ltd
2023/11/0818:54GlobeNewswire Inc.TLC to Present Phase 3 Data of TLC599 in Late-Breaking Abstracts Session at ACRNASDAQ:TLCTaiwan Liposome Company Ltd
2022/06/1319:30GlobeNewswire Inc.TLC Announces TLC599 Agreement with EndoNASDAQ:TLCTaiwan Liposome Company Ltd
2022/03/0718:57GlobeNewswire Inc.TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & TherapyNASDAQ:TLCTaiwan Liposome Company Ltd
2022/02/1906:04Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TLCTaiwan Liposome Company Ltd
2022/01/2720:13Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/10/2105:09Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/10/1519:33Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/09/1605:02Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/09/1600:57Edgar (US Regulatory)Appointment of Agent for Service of Process and Undertaking (f-x)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/09/0905:11Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/09/0817:40GlobeNewswire Inc.TLC Announces Voluntary Delisting and Deregistration of American Depositary SharesNASDAQ:TLCTaiwan Liposome Company Ltd
2021/08/2705:11Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/08/2705:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/08/2505:02Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/08/2105:08Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/08/1218:44GlobeNewswire Inc.TLC Reports Second Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:TLCTaiwan Liposome Company Ltd
2021/08/0701:51Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/08/0603:38Edgar (US Regulatory)Tender Offer/rights Offering Notification (cb)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/08/0422:14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/07/2219:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/07/0806:19Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/07/0619:44Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/07/0519:16GlobeNewswire Inc.TLC Announces Details of Stock Swap TransactionsNASDAQ:TLCTaiwan Liposome Company Ltd
2021/05/2617:30GlobeNewswire Inc.TLC and Zydus Enter Agreement to Launch AmphoTLC™ in IndiaNASDAQ:TLCTaiwan Liposome Company Ltd
2021/05/2518:05GlobeNewswire Inc.TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in IndiaNASDAQ:TLCTaiwan Liposome Company Ltd
2021/05/2322:00GlobeNewswire Inc.InspirMed Highlights Encouraging Data on ISPM21 and ISPM19 – Inhalable Liposome Formulations of Antiviral Drugs for COVID-1...NASDAQ:TLCTaiwan Liposome Company Ltd
2021/05/1420:32GlobeNewswire Inc.TLC Reports First Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:TLCTaiwan Liposome Company Ltd
2021/05/1420:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
2021/05/0318:15GlobeNewswire Inc.TLC Earns Highest Ranking in Corporate Governance Evaluation Seven Years RunningNASDAQ:TLCTaiwan Liposome Company Ltd
 검색 관련기사 보기:NASDAQ:TLC